title: [Value of prevention of congenital toxoplasmosis].
abstract: OBJECTIVE
  To verify incidence of toxoplasmosis seroconversion during pregnancy and the interest of treating the mother.
  
  
  METHODS
  Among 7044 infants born between January 1989 and December 1993, 78 (1.1%) born to mothers who developped toxoplasmosis seroconversion during pregnancy were followed.
  
  
  RESULTS
  Among 69 mothers treated, there were only 9 cases of congenital toxoplasmosis (13.4%) including only 3 cases of patent toxoplasmosis.
  
  
  CONCLUSIONS
  Treating the mother is an effective means of preventing toxoplasmosis. The cost of verifying seronegativity in women during pregnancy could be reduced by primary prevention.
authors: Service d'Ophtalmologie, Centre Hospitalier, Montreuil.
authors: C
authors: C
authors: Douche
authors: A
authors: A
authors: Benabdesselam
authors: F
authors: F
authors: Mokhtari
authors: Y
authors: Y
authors: Le Mer
mesh_terms: D003049:Coccidiostats / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy* / Q000276:immunology; D012307:Risk Factors; D012698:Serologic Tests; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000276:immunology; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control*
chemical_list: D003049:Coccidiostats
vernacular_title: Intérêt de la prévention de la toxoplasmose congénitale.